Dachaigh › Luchd-obrach › Nuvation Bio Inc
Nuvation Bio Inc: Tuarastalan H-1B agus taic bhìosa
Chuir Nuvation Bio Inc 17 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 16. Tuarastal meadhanach a chaidh a thabhann: $235,000.
A bheil Nuvation Bio Inc a’ toirt taic do bhìosaichean H-1B?
Chuir Nuvation Bio Inc 17 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 1 Ògmh 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| VP, Head of Clinical Operations | 4 | $354,000 |
| Director, Business Intelligence and Data Management | 2 | $220,000 |
| Director-Field Systems and Digital Enablement | 2 | $235,000 |
| Associate Director of Business Development | 2 | $163,297 |
| Vice President, Clinical Operations | 2 | $370,000 |
| Director of Corporate Development | 2 | $250,000 |
| Senior Scientist | 2 | $170,990 |
| Scientist I | 1 | $151,318 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 3 | $350,000 |
| FY2024 | 2 | $220,000 |
| FY2025 | 3 | $358,000 |
| FY2026 | 9 | $202,995 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Medical and Health Services Managers4
- Computer and Information Systems Managers4
- Medical Scientists, Except Epidemiologists3
- Market Research Analysts and Marketing Specialists2
- Natural Sciences Managers2
- Financial and Investment Analysts2
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior Scientist | $170,990 Ìre IV | New York, NY | 1 Ògmh 2026 | 4 Sult 2026 | Dearbhaichte |
| Associate Director of Business Development | $168,819 Ìre IV | Jersey City, NJ | 27 Cèit 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Senior Scientist | $170,990 Ìre IV | New York, NY | 27 Cèit 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Director of Corporate Development | $250,000 Ìre IV | New York, NY | 13 Cèit 2026 | 20 Cèit 2026 | Dearbhaichte |
| Director of Corporate Development | $250,000 Ìre IV | New York, NY | 12 Cèit 2026 | 20 Cèit 2026 | Dearbhaichte |
| Vice President, Clinical Operations | $370,000 Ìre IV | San Francisco, CA | 8 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Vice President, Clinical Operations | $370,000 Ìre IV | San Francisco, CA | 8 Gibl 2026 | 1 Dàmh 2026 | Air a tharraing air ais |
| Director-Field Systems and Digital Enablement | $235,000 Ìre IV | The Colony, TX | 27 Faoi 2026 | 5 Gearr 2026 | Dearbhaichte |
| Associate Director of Business Development | $157,775 Ìre IV | Jersey City, NJ | 8 Faoi 2026 | 15 Faoi 2026 | Dearbhaichte |
| VP, Head of Clinical Operations | $358,000 E-3 · Ìre IV | San Francisco, CA | 25 Gearr 2025 | 6 Gibl 2025 | Dearbhaichte |
| VP, Head of Clinical Operations | $358,000 E-3 · Ìre IV | San Francisco, CA | 12 Dùbh 2024 | 6 Gibl 2025 | Dearbhaichte |
| Director-Field Systems and Digital Enablement | $235,000 Ìre III | New York, NY | 14 Dàmh 2024 | 12 Samh 2024 | Dearbhaichte |
| Director, Business Intelligence and Data Management | $220,000 Ìre II | San Jose, CA | 17 Sult 2024 | 25 Sult 2024 | Dearbhaichte |
| Director, Business Intelligence and Data Management | $220,000 Ìre II | San Jose, CA | 12 Sult 2024 | 20 Sult 2024 | Dearbhaichte |
| Scientist I | $151,318 Ìre IV | New York, NY | 14 Ògmh 2023 | 1 Dàmh 2023 | Dearbhaichte |
| VP, Head of Clinical Operations | $350,000 E-3 · Ìre IV | San Francisco, CA | 1 Màrt 2023 | 7 Gibl 2023 | Dearbhaichte |
| VP, Head of Clinical Operations | $350,000 E-3 · Ìre IV | New York, NY | 28 Gearr 2023 | 7 Gibl 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).